Robert W. Baird analyst Eric Coldwell maintained a Buy rating on McKesson (MCK – Research Report) today and set a price target of $797.00. The company’s shares opened today at ...

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

Quest Diagnostics Incorporated (NYSE:DGX), a prominent provider of diagnostic testing and information services, has hit a record-breaking share price of $180.11, pushing the company’s market ...

Aquestive Therapeutics' Anaphylm offers a unique, non-injectable epinephrine solution for anaphylaxis. Read why AQST stock is ...

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products and Therapies ...

At close: June 9 at 4:00:01 p.m. EDT ...